0001209191-22-006486.txt : 20220202
0001209191-22-006486.hdr.sgml : 20220202
20220202173702
ACCESSION NUMBER: 0001209191-22-006486
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220202
DATE AS OF CHANGE: 20220202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Perrin Steven
CENTRAL INDEX KEY: 0001824545
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 22585037
MAIL ADDRESS:
STREET 1: C/O ANELIXIS THERAPEUTICS, INC.
STREET 2: 1500 DISTRICT AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 949-238-8090
MAIL ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
FORMER COMPANY:
FORMER CONFORMED NAME: Novus Therapeutics, Inc.
DATE OF NAME CHANGE: 20170511
FORMER COMPANY:
FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070622
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-01
0
0001404281
Eledon Pharmaceuticals, Inc.
ELDN
0001824545
Perrin Steven
C/O ELEDON PHARMACEUTICALS, INC.
19900 MACARTHUR BLVD STE. 550
IRVINE
CA
92612
1
1
0
0
President
Stock Option (right to buy)
3.97
2022-02-01
4
A
0
155000
0.00
A
2032-02-01
Common Stock
155000
155000
D
This option represents a right to purchase up to 155,000 shares of Common Stock, which option vests with respect to 38,750 shares on February 1, 2023, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending February 1, 2026.
/s/ Steve Perrin
2022-02-02